Written and medically reviewed by: Assoc. Prof. Cengiz Dibekoğlu, MD, General SurgeryLast updated:
Breast Disease — Breast Screening and Follow-up
Turkey’s 40–69 biennial mammography program, high-risk MRI pathways, pregnancy/breastfeeding imaging rules, and post-cancer surveillance — compressed into a practical map.
Breast care runs on two tracks: evaluation of symptoms, and asymptomatic periodic screening. Mammography/tomosynthesis is the backbone screening tool for average-risk adults in Turkey’s Ministry of Health program (biennial ages 40–69 via centers such as KETEM). Ultrasound is supplementary — for dense breasts, symptomatic evaluation, or problem-solving — not a population-wide substitute for mammography. High-risk people follow a different calendar that may add MRI. US screening intervals differ among ACS, USPSTF, and other groups; any age-specific US recommendation should name its source year.
Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.
© Cengiz Dibekoğlu — illustrative; not for unauthorized use
Figure summary
- Labeled on this figure: Awareness · Clinical exam · Imaging.
- Related figures on this page: Mammography, US, MRI, After treatment: surveillance.
Figure labels (English)
- Awareness
- Clinical exam
- Imaging
Related educational figures
Tap a figure to enlarge.
Mammography, US, MRI Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.
© Cengiz Dibekoğlu — illustrative; not for unauthorized use
Figure summary
Mammography, US, MRI
After treatment: surveillance Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.
© Cengiz Dibekoğlu — illustrative; not for unauthorized use
Figure summary
After treatment: surveillance
Who may be a candidate?
- Average-risk women planning age-appropriate mammography in Turkey
- High-risk individuals needing earlier, denser protocols including MRI
- Pregnant or breastfeeding patients with new breast symptoms
- Survivors needing post-treatment imaging and clinical follow-up
Possible advantages
- National 40–69 biennial mammography gives a clear average-risk backbone
- High-risk MRI pathways catch disease earlier in genetically elevated risk
- Pregnancy/breastfeeding rules prioritise ultrasound so diagnosis is not deferred to delivery
Limits & realistic expectations
- Dense breasts may need ultrasound added to mammography
- Average-risk calendars must not be applied unchanged to high-risk genetics
- Self-awareness never replaces scheduled mammography
Step-by-step overview
- 1
Know your risk lane
Average-risk population screening differs from genetic/family high-risk protocols — confirm which lane you are in.
- 2
Keep the three pillars
Breast awareness, clinical examination, and age-appropriate imaging work together; none fully replaces the others.
- 3
Match the modality
Screening mammography (± ultrasound if dense); ultrasound first for young, pregnant, or symptomatic patients; MRI for selected high-risk or problem-solving cases.
- 4
Act on new findings
New lumps, skin or nipple change, bloody discharge, or axillary swelling skip the waiting list for the next screen — seek earlier review.
Key points
Three pillars of control
Breast awareness (knowing your normal), clinical breast examination, and age-appropriate imaging (mammography ± ultrasound ± MRI) work together. None replaces the others; awareness never cancels a scheduled mammogram.
- Awareness: notice change early
- Clinical exam: clinician assessment
- Imaging: mammography / ultrasound / MRI
- Key note inside
Average risk before 40, and ages 40–69 in Turkey
Before 40, routine mammography is usually not advised for average risk; symptoms lead with exam and ultrasound. From 40–69, Turkey’s Ministry of Health program recommends mammography every two years. Dense tissue may add ultrasound; high-risk people use a separate, denser calendar.
- Turkey (Ministry of Health): ages 40–69
- Frequency: mammography every two years
- Dense breasts: consider added ultrasound
- High risk: separate, more intensive protocol
- Key note inside
Later life and high-risk intensification
Benefit–harm balance is clearest in mid-life; continuing after 70 depends on health and life expectancy. High-risk pathways often start around ages 25–30 (or 10 years before the earliest family diagnosis) with annual mammography plus annual MRI when indicated — genetics counseling may accompany this.
- Genetic or strong family history
- Prior chest radiotherapy
- Atypia / LCIS history
- Often: annual mammography + MRI
Choosing mammography, ultrasound, or MRI
Screening: mammography/tomosynthesis is the backbone tool — not “mammography or ultrasound by age.” Ultrasound supplements dense breasts, symptoms, or problem-solving; it does not replace scheduled mammography for average-risk screening. MRI serves high-risk pathways and selected staging. US note: ACS (2023), USPSTF (2024 draft), and other groups differ on start age and interval — name the guideline when citing US screening advice.
- Key note inside
Pregnancy and breastfeeding
Concerning breast symptoms in pregnancy are not deferred to delivery: exam, then ultrasound first; shielded mammography only if needed; contrast MRI generally avoided; biopsy when indicated is not delayed. During lactation the path is similar — empty the breast before imaging; non-resolving redness or mass needs imaging ± biopsy rather than prolonged ‘mastitis only’ assumptions.
- 1. Clinical examination
- 2. Ultrasound first
- 3. Shielded mammography if still needed
- 4. Contrast MRI: usually avoided / special decision
- 5. Biopsy not deferred when suspicion persists
After benign findings and after cancer treatment
Simple cysts often return to the routine screen. Typical fibroadenomas may have 6–12 month ultrasound checks. BI-RADS 3 lesions classically use short-interval follow-up (for example 6 months). After cancer treatment, early-year clinic visits are denser; conserved breasts usually have annual mammography and the other breast continues screening; mastectomy sides rely on exam ± selective ultrasound/MRI, plus systemic aftercare.
- BI-RADS 3: short-interval imaging (e.g. 6 months)
- Simple cyst: often back to routine screening
- Post-cancer: closer clinical visits early, then spaced
- Key note inside
Do not wait for the next screen if…
A new palpable lump, skin or nipple change, bloody or unilateral discharge, axillary swelling, or peau d’orange/redness is a reason for early clinical assessment — not a reason to wait for the next screening appointment.
- Key note inside
Important
Educational information only — this page is for education and does not replace a visit with your physician. Screening age and frequency are individual; national programs set a backbone, and high-risk or post-cancer plans differ. Seek care promptly for new lumps, discharge, or skin change.
Frequently asked questions
What is Turkey’s average-risk mammography schedule?
The Ministry of Health program recommends mammography every two years for average-risk women aged 40–69. Dense breasts may add ultrasound; some individual plans discuss annual mammography.
Who needs MRI screening?
High-risk people — for example pathogenic BRCA1/2 or other high-penetrance mutations, strong family history, prior chest radiotherapy at a young age, or markedly elevated lifetime risk — often follow annual mammography plus annual breast MRI.
How is imaging sequenced in pregnancy?
Do not defer concerning symptoms until delivery. Clinical exam then ultrasound first (no ionizing radiation). Shielded mammography only if suspicion remains; contrast MRI is generally avoided. Biopsy is not postponed when indicated.
What about breastfeeding?
Exam plus ultrasound first; emptying the breast before imaging improves quality. Mammography when needed is allowed. Non-resolving redness or mass must not be dismissed as mastitis alone.
How does follow-up change after breast cancer treatment?
Clinical visits are closer in early years. Conserved breasts usually have annual mammography; the contralateral breast continues screening. After mastectomy, routine mammography of that side is not used — exam ± ultrasound/MRI as indicated.
More chapters in this hub
Breast Cysts and Benign Lesions
Simple cysts, fibroadenoma, and when biopsy is discussed
Breast Disease Diagnosis
How clinicians confirm the problem and stage the next steps
Breast Cancer
Cancer — explained for shared decision-making
Breast Cancer Treatment
How treatment options are matched to risk, stage, and goals
Multidisciplinary Breast Care
Multidisciplinary — explained for shared decision-making
Appointment / info
This page is for education. It is not medical advice and does not replace a visit with your physician.
Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.